Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Cantor Fitzgerald

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050756

« Back to Dashboard

NDA 050756 describes BENZACLIN, which is a drug marketed by Valeant Bermuda and is included in one NDA. It is available from three suppliers. Additional details are available on the BENZACLIN profile page.

The generic ingredient in BENZACLIN is benzoyl peroxide; clindamycin phosphate. There are seventeen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the benzoyl peroxide; clindamycin phosphate profile page.

Summary for 050756

Formulation / Manufacturing:see details

Pharmacology for NDA: 050756

Physiological EffectDecreased Sebaceous Gland Activity

Suppliers and Packaging for NDA: 050756

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BENZACLIN benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 050756 NDA Valeant Pharmaceuticals North America LLC 0187-5190 0187-5190-25 1 JAR in 1 CARTON (0187-5190-25) > 25 g in 1 JAR
BENZACLIN benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 050756 NDA Valeant Pharmaceuticals North America LLC 0187-5190 0187-5190-35 1 BOTTLE, PUMP in 1 CARTON (0187-5190-35) > 35 g in 1 BOTTLE, PUMP

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength5%;EQ 1% BASE
Approval Date:Dec 21, 2000TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:GEL;TOPICALStrength5%;EQ 1% BASE
Approval Date:Apr 20, 2007TE:RLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald
Chinese Patent Office
Queensland Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: